UCL awarded £6.8million for NIHR Global Health Research Unit
14 July 2017
The NIHR Global Health Research Unit on Mucosal Pathogens will support research in to combatting pneumonia, meningitis and sepsis in lower and middle income countries.
Professor Rob Heyderman has been awarded £6.8 million by NIHR to establish a Mucosal Pathogens Unit (MPRU), to support research in to combatting pneumonia, meningitis and sepsis in lower and middle income countries.
The MPRU aims to address the limitations in the long-term effectiveness of vaccines though new approaches to interrupting mucosal pathogen carriage and transmission, and so the development of pneumonia, meningitis and sepsis. An important focus of the MPRU's work will be the training of early career scientists in research - the people who will become future research leaders.
Based at the Division of Infection and Immunity, UCL, the MPRU has forged partnerships with the Universities of Edinburgh, Liverpool, Oxford and Southampton, Liverpool School of Tropical Medicine, London School of Hygiene and Tropical Medicine and BUGs Bioscience in the UK with research centres in Kenya, Malawi, Mali, South Africa and The Gambia.
The research programme will improve disease intelligence; develop new measures of immunity; test novel Interventions including vaccines; respond to outbreaks; and engage in a two-way dialogue with the public & policymakers.